Vinisha Saldanha

Johnson & Johnson Innovative Medicine

06.2025 - Current

Leading a team of medical affairs professionals for the oncology portfolio which includes Hematology and Solid Tumors with key responsibilities of brand planning, budget management, launch excellence and therapy shaping for innovator & global focused brands Darzalex, Rybrevant & Tecvayli
Fostering a strong interface with cross-functional teams to enable a one team mindset, build a high-performance culture and achieve excellence in execution as the team prepared for launch of Tecvayli
Build partnerships with scientific societies and KOL’s to drive scientific leadership for multiple myeloma
Collaborated with regulatory team to support the SEC strategy for key assets and indications
Implemented capability building measures to improve employees'' skills and knowledge, increasing overall efficiency.
Improved KOL connect standards by setting clear expectations to team members and providing ongoing support as needed.
Enhanced team productivity by implementing efficient processes and streamlining workflow.

Bayer Zydus Pharma Pvt Ltd

02.2022 - 05.2024

Leading team of 10 Medical Science Liaisons (MSL) and 1 Medical advisor(MA) to consistently meet business objectives and TL advocacy for Heart Health(HH) brands
Strategize, collaborate & execute pre-launch, launch & post launch activities for creating disease awareness and establishing the value of therapy in WHF space
Lead the publication strategy to increase disease awareness and scientific share of voice for Verquvo
Drive team members to execute brand strategy and TL engagement plan- Including identification, profiling, sentiment mapping and achieving TL advocacy through robust TL engagement
Drive and sustain high performance culture as well as growth mindset amongst the team members through coaching and development plan

Bayer Zydus Pharma Pvt Ltd

01.2019 - 01.2022

Lead medical strategy for HA approval of Xarelto vascular dose for the CAD/ PAD indication
Formulate the medical strategy in alignment with the brand strategy to drive best in class launch of the CAD/ PAD indication
Drive pre-launch and launch activities for the CAD/PAD indication
Formulated Renal-in-a-box and safety messaging to strengthen the safety narrative and drive consistency in communication across all scientific forums
Formulate the medical affairs plan to support the brand strategy in preparation of LOE
Driving product differentiation, planning & tracking of KOL engagements and change sentiment status, based on MSL insights and market research reports
Lead the medical strategy for new drug approval of vericiguat in worsening heart failure(WHF) in India 2021
Drive pre-launch activation of medical strategy to create disease awareness and shape the market for successful launch.

Bayer Zydus Pharma Pvt Ltd

01.2015 - 01.2019

Develop & drive the medical strategy for the No.1 NOAC and biggest brand for Bayer in India, while also managing the primary care portfolio of established products
Develop medical strategy for Xarelto aligned with the local brand strategy to drive successful launch of SPAF & VTE indications
Collaborate with international & national TL’s to achieve brand advocacy through medical engagement activities-Ad Boards, International speaker programs, Expert group meetings.
Developed and executed integrated thought leader management plan (ITLM) to drive strategic imperatives according to TL priorities through an integrated cross-functional approach.
Collaborate with MSL’s as well as field commercial team to obtain insights that will support brand strategy
Conceptualize and design phase 4/observational studies as a part evidence generation plan for Xarelto.

Summary